REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION (RT-PCR) ANALYSIS OF MONOAMINE TRANSPORTERS IN NEUROBLASTOMA CELL-LINES - CORRELATIONS TO METAIODOBENZYLGUANIDINE (MIBG) UPTAKE AND TYROSINE-HYDROXYLASE GENE-EXPRESSION

被引:53
作者
LODE, HN [1 ]
BRUCHELT, G [1 ]
SEITZ, G [1 ]
GEBHARDT, S [1 ]
GEKELER, V [1 ]
NIETHAMMER, D [1 ]
BECK, J [1 ]
机构
[1] BYK GULDEN LOMBERG GMBH, D-78403 CONSTANCE, GERMANY
关键词
NEUROBLASTOMA; MIBG UPTAKE; NORADRENALINE TRANSPORTER; TYROSINE HYDROXYLASE; GENE EXPRESSION; CATECHOLAMINES;
D O I
10.1016/0959-8049(95)00039-L
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radiolabelled meta-iodobenzylguanidine (MIBG) has been widely used in scintigraphy and targeted radiotherapy in patients with neuroblastoma. Recently, it has been demonstrated that MIBG is incorporated into neuroblastoma cells by the noradrenaline transporter. In vitro experiments on SK-N-SH human neuroblastoma cells performed in the present study showed that uptake of MIBG is inhibited by noradrenaline, more so by dopamine and to a lesser extent, by serotonin, indicating that the respective transporters may also contribute to MIBG uptake. However, neither dopamine nor serotonin transporter gene expression was detected. Noradrenaline transporter gene expression was found in 4 of 6 investigated cell lines, which correlated with specific MIBG uptake. Furthermore, an inverse correlation of noradrenaline transporter and tyrosine hydroxylase gene expression, the key regulatory enzyme of catecholamine synthesis, was observed. These data show that MIBG is specifically incorporated only in neuroblastoma cells in which there is noradrenaline transporter gene expression. Furthermore, the catecholamine status in neuroblastoma cells is regulated by a coordinate expression of the key elements of catecholamine synthesis and reuptake systems.
引用
收藏
页码:586 / 590
页数:5
相关论文
共 26 条
[1]  
BUCK J, 1985, CANCER RES, V45, P636
[2]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[3]  
GLOWNIAK JV, 1993, J NUCL MED, V34, P1140
[4]  
IVARONE A, 1993, CANCER RES, V53, P304
[5]  
JAQUES S, 1984, MOL PHARMACOL, V26, P539
[6]   A COMBINED EVALUATION OF BIOCHEMICAL AND MORPHOLOGICAL-CHANGES DURING HUMAN NEUROBLASTOMA CELL-DIFFERENTIATION [J].
LANCIOTTI, M ;
MONTALDO, PG ;
FOLGHERA, S ;
LUCARELLI, E ;
CORNAGLIAFERRARIS, P ;
PONZONI, M .
CELLULAR AND MOLECULAR NEUROBIOLOGY, 1992, 12 (03) :225-240
[7]   PHASE I/II STUDY OF I-131 METAIODOBENZYLGUANIDINE IN CHEMORESISTANT NEUROBLASTOMA - A UNITED-KINGDOM CHILDRENS CANCER STUDY-GROUP INVESTIGATION [J].
LASHFORD, LS ;
LEWIS, IJ ;
FIELDING, SL ;
FLOWER, MA ;
MELLER, S ;
KEMSHEAD, JT ;
ACKERY, D .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1889-1896
[8]   METAIODOBENZYLGUANIDINE (METAIODOBENZYLGUANIDINE) UPTAKE AND STORAGE IN THE HUMAN NEUROBLASTOMA CELL-LINE SK-N-BE(2C) [J].
LASHFORD, LS ;
HANCOCK, JP ;
KEMSHEAD, JT .
INTERNATIONAL JOURNAL OF CANCER, 1991, 47 (01) :105-109
[9]   THE UPTAKE AND RETENTION OF METAIODOBENZYL GUANIDINE BY THE NEUROBLASTOMA CELL-LINE NB1-G [J].
MAIRS, RJ ;
GAZE, MN ;
BARRETT, A .
BRITISH JOURNAL OF CANCER, 1991, 64 (02) :293-295
[10]   PREDICTION OF ACCUMULATION OF I-131-LABELED METAIODOBENZYLGUANIDINE IN NEUROBLASTOMA CELL-LINES BY MEANS OF REVERSE TRANSCRIPTION AND POLYMERASE CHAIN-REACTION [J].
MAIRS, RJ ;
LIVINGSTONE, A ;
GAZE, MN ;
WHELDON, TE ;
BARRETT, A .
BRITISH JOURNAL OF CANCER, 1994, 70 (01) :97-101